INTELLISKIN USA, LLC – Trademark Portfolio
Entity Type: 16
INTELLISKIN USA, LLC holds 16 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 25 (Clothing) — 15 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 5 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include POSTURECUE and INTELLISKIN. The owner is based in Newport Beach, CA.
20162 SW Birch Street, Suite 125
Newport Beach, CA 926600787
Showing of trademarks Trademarks
Trademark Classifications
INTELLISKIN USA, LLC's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Advertising; business management; business administration; office functions
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does INTELLISKIN USA, LLC have?
INTELLISKIN USA, LLC has 16 U.S. trademarks filed with the USPTO. Of these, 4 registered, 6 abandoned, 6 cancelled.
What trademark classes does INTELLISKIN USA, LLC file in?
INTELLISKIN USA, LLC files trademarks across 5 Nice Classification classes. The most active classes are Class 25 (Clothing), Class 44 (Medical Services), Class 35 (Advertising & Business), Class 41 (Education & Entertainment), Class 10 (Medical Apparatus). Class 25 covers clothing, footwear, headgear.
What are INTELLISKIN USA, LLC's most well-known trademarks?
INTELLISKIN USA, LLC's registered trademark portfolio includes well-known marks such as POSTURECUE and INTELLISKIN. These are among 4 currently registered trademarks in the portfolio.
What is INTELLISKIN USA, LLC's trademark registration success rate?
INTELLISKIN USA, LLC has a 25% trademark registration rate, with 4 out of 16 resolved applications resulting in successful registration. Currently, 0 applications are pending review.